{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-25-000826","form_type":"8-K","ticker":"ACTU","cik":"0001652935","company_name":"ACTUATE THERAPEUTICS, INC.","filed_at":"2025-02-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.317653+00:00","generated_at":"2026-05-27T00:56:05.944534+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Actuate Therapeutics sets first annual meeting for May 22, 2025; deadlines announced","bullets":["First Annual Meeting of Stockholders will be held virtually on May 22, 2025.","Record date for voting entitlement is March 25, 2025.","Rule 14a-8 stockholder proposals must be received by February 21, 2025, for proxy inclusion.","Advance notice for director nominations and other proposals also due by February 21, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-25-000826","json":"https://secwatch.observer/filing/0001683168-25-000826.json","markdown":"https://secwatch.observer/filing/0001683168-25-000826.md","text":"https://secwatch.observer/filing/0001683168-25-000826.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1652935/000168316825000826/0001683168-25-000826-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1652935/000168316825000826/actuate_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T00:56:05.944534+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}